Marc Peeters Selected Research

Cholangiocarcinoma

7/2022	Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma: a case report.
2/2017	Targeting Angiogenesis in Biliary Tract Cancers: An Open Option.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Peeters Research Topics

Disease

134	Neoplasms (Cancer) 03/2024 - 03/2006
81	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 09/2005
17	Neoplasm Metastasis (Metastasis) 08/2022 - 09/2005
16	Adenocarcinoma 03/2024 - 08/2005
16	Squamous Cell Carcinoma of Head and Neck 01/2023 - 05/2010
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 06/2011
12	Hypoxia (Hypoxemia) 01/2020 - 03/2006
11	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024 - 10/2008
11	Disease Progression 02/2021 - 08/2005
8	Breast Neoplasms (Breast Cancer) 07/2023 - 01/2014
8	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 10/2010
6	Carcinoma (Carcinomatosis) 01/2023 - 08/2005
6	Colonic Neoplasms (Colon Cancer) 10/2022 - 02/2011
5	Carcinogenesis 01/2023 - 09/2017
5	Lung Neoplasms (Lung Cancer) 08/2022 - 05/2010
5	Fatigue 10/2019 - 12/2011
4	Deglutition Disorders (Dysphagia) 01/2023 - 09/2015
4	Primitive Neuroectodermal Tumors (PNET) 05/2018 - 04/2015
3	Stomach Neoplasms (Stomach Cancer) 01/2023 - 11/2014
3	Inflammation (Inflammations) 07/2022 - 01/2016
3	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2018
3	Circulating Neoplastic Cells 04/2021 - 12/2014
3	Rectal Neoplasms (Rectal Cancer) 04/2021 - 02/2007
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2019 - 01/2018
3	Vomiting 01/2017 - 04/2009
3	Exanthema (Rash) 12/2011 - 04/2009
2	Pain (Aches) 07/2022 - 11/2017
2	Body Weight (Weight, Body) 07/2022 - 11/2011
2	Cholangiocarcinoma 07/2022 - 02/2017
2	COVID-19 01/2022 - 11/2021
2	Microsatellite Instability 12/2021 - 09/2019
2	Ovarian Neoplasms (Ovarian Cancer) 10/2021 - 02/2008
2	Lymphatic Metastasis 01/2021 - 05/2019
2	Triple Negative Breast Neoplasms 01/2020 - 01/2014

Drug/Important Bio-Agent (IBA)

32	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2010
32	ErbB Receptors (EGF Receptor)IBA 03/2024 - 04/2008
27	Panitumumab (Vectibix)FDA Link 06/2023 - 05/2007
23	Cetuximab (Erbitux)FDA Link 01/2023 - 09/2008
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2009
15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 09/2005
10	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 04/2008
10	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 04/2009
10	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 04/2009
10	Monoclonal AntibodiesIBA 10/2020 - 11/2010
10	Gemcitabine FDA Link 01/2017 - 08/2005
9	Leucovorin (Folinic Acid)FDA Link 01/2023 - 04/2009
9	Messenger RNA (mRNA)IBA 08/2022 - 10/2009
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2019 - 02/2008
8	Bevacizumab (Avastin)FDA Link 03/2024 - 11/2011
7	Cell-Free Nucleic AcidsIBA 10/2022 - 01/2018
6	Immune Checkpoint InhibitorsIBA 04/2023 - 01/2018
6	regorafenibIBA 12/2021 - 11/2014
5	Phosphotransferases (Kinase)IBA 01/2022 - 11/2010
5	LigandsIBA 01/2022 - 10/2009
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 11/2012
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2014
5	Circulating Tumor DNAIBA 03/2019 - 12/2014
5	Cisplatin (Platino)FDA LinkGeneric 04/2018 - 09/2015
4	BNT162 VaccineIBA 01/2023 - 01/2022
4	Formaldehyde (Formol)FDA Link 08/2022 - 10/2009
4	ParaffinIBA 08/2022 - 10/2009
4	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2016
3	Auranofin (Ridaura)FDA Link 03/2024 - 01/2021
3	Tyrosine Kinase InhibitorsIBA 07/2022 - 07/2009
3	CytokinesIBA 01/2022 - 09/2020
3	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 03/2015
3	ChemokinesIBA 01/2022 - 01/2018
3	PlatinumIBA 01/2021 - 01/2016
3	AntibodiesIBA 10/2020 - 10/2018
3	Polo-Like Kinase 1IBA 11/2019 - 01/2017
3	BI 6727IBA 11/2019 - 10/2015
3	Oxygen (Dioxygen)IBA 10/2019 - 06/2015
3	AfatinibIBA 01/2019 - 10/2015
3	SirtuinsIBA 12/2018 - 01/2016
3	trifluridine tipiracil drug combinationIBA 07/2018 - 05/2015
3	Yttrium-90IBA 01/2017 - 08/2010
3	Everolimus FDA Link 03/2016 - 12/2011
3	Sunitinib (Sutent)FDA Link 11/2014 - 07/2009
3	Glucose (Dextrose)FDA LinkGeneric 01/2009 - 02/2008
2	MK 2206IBA 03/2024 - 01/2021
2	olaparibIBA 07/2023 - 06/2016
2	TroponinIBA 04/2023 - 07/2022
2	Hormones (Hormone)IBA 01/2023 - 01/2020
2	matrigelIBA 01/2023 - 06/2011
2	NivolumabIBA 07/2022 - 04/2021
2	VaccinesIBA 01/2022 - 01/2022
2	thiamine triphosphorate (TTP)IBA 01/2022 - 08/2010
2	Poly I-CIBA 06/2021 - 01/2018
2	Interleukin-15 (Interleukin 15)IBA 01/2020 - 08/2017

Therapy/Procedure

68	Therapeutics 03/2024 - 04/2009
35	Drug Therapy (Chemotherapy) 03/2024 - 09/2005
19	Radiotherapy 10/2023 - 03/2006
12	Immunotherapy 01/2024 - 04/2012
5	Chemoradiotherapy 01/2021 - 10/2010
3	Neoadjuvant Therapy 10/2022 - 02/2007
3	Continuity of Patient Care 07/2018 - 08/2013
3	Microspheres (Microsphere) 01/2017 - 08/2010
2	Precision Medicine 12/2023 - 12/2014
2	Aftercare (After-Treatment) 08/2022 - 11/2011
2	Drug Tapering 01/2020 - 01/2018